Home

ASSOCIATES IV L P VENROCK

CIK 1277997 · last filed 2018-09-12

ASSOCIATES IV L P VENROCK is a corporate insider who has filed 6 SEC Form 4 insider transactions across 3 companies since 2012. The most recent filing shows the insider bought $2.8M of BLPH on Sep 12, 2018. Across all open-market trades the lifetime net is +$3.8M, making them a net buyer over the disclosed history. 23 SEC filings were submitted jointly with VEF Management IV, LLC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

6

Lifetime Open-Market Net

$3.76M

Filer Profile

Reported Address
3340 HILLVIEW AVENUE
PALO ALTO, CA 94304
Phone
(650) 475-3734
Related Filers
VEF Management IV, LLC — 23 joint filings, latest 2019-10-28
VENROCK ENTREPRENEURS FUND IV L P — 23 joint filings, latest 2019-10-28
Venrock Partners, L.P. — 23 joint filings, latest 2019-10-28
Bong Y Koh — 7 joint filings, latest 2019-10-28
Nimish P Shah — 7 joint filings, latest 2019-10-28
VHCP Co-Investment Holdings II, LLC — 7 joint filings, latest 2019-10-28
Venrock Healthcare Capital Partners II, L.P. — 7 joint filings, latest 2019-10-28
VHCP Co-Investment Holdings III, LLC — 5 joint filings, latest 2019-10-28
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Bellerophon Therapeutics, Inc. (BLPH) Delisted 10%+ Owner 478,411 $0.01 $5.7K $6.91M 3 2018-09-12
Achaogen, Inc. (AKAO) Delisted 10%+ Owner 1,746,461 — — $0 1 2014-03-17
Anacor Pharmaceuticals, Inc. (ANAC) Delisted 10%+ Owner 3,725,535 $10.19 $37.96M -$3.14M 2 2012-09-24

Recent Filings

6 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2018-09-12 Bellerophon Therapeutics, Inc. (BLPH) Delisted Buy (P) +2,375,000 $2.79M EDGAR
2018-08-16 Bellerophon Therapeutics, Inc. (BLPH) Delisted Buy (P) +5,293,700 $3.43M EDGAR
2018-08-16 Bellerophon Therapeutics, Inc. (BLPH) Delisted Buy (P) +1,058,740 $685.8K EDGAR
2014-03-17 Achaogen, Inc. (AKAO) Delisted Conv (C) +10,478,766 $0 EDGAR
2012-09-24 Anacor Pharmaceuticals, Inc. (ANAC) Delisted Sell (S) −173,457 -$1.09M EDGAR
2012-09-18 Anacor Pharmaceuticals, Inc. (ANAC) Delisted Sell (S) −315,000 -$2.05M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.